Skip to content

The influences of accuracy anesthesia with individualized lung protective ventilation strategies on the postoperative pulmonary complications and outcome qualities in obese patients undergoing major surgery

The influences of accuracy anesthesia with individualized lung protective ventilation strategies on the postoperative pulmonary complications and outcome qualities in obese patients undergoing major surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097968
Enrollment
Unknown
Registered
2025-02-28
Start date
2025-02-28
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Control group:Clinical routine anesthesia management protocol
Experimental group:Accuracy anesthesia management with individualized lung protection protocol

Sponsors

Ruijin Hospital Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients who have signed the informed consent form and can communicate well 2. Adult obese patients, 18 years old=30 kg/m2 4. Those who have undergone major surgical treatment with tracheal intubation under general anesthesia, and the predicted operation time is > 2 hours 5. No serious respiratory diseases such as emphysema and pulmonary bullae before surgery 6. Patients who are not admitted to the ICU for treatment after surgery 7. Promise to abide by the research procedures and cooperate with the implementation of the whole process of research

Exclusion criteria

Exclusion criteria: 1. Patients undergoing cardiac, thoracic surgery, obstetric and neurosurgical procedures 2. Severe heart disease, decreased cardiac output and/or severe hypotension 3. Patients with severe cerebral ischemia and/or intracranial hypertension 4. Patients who are unable to communicate effectively 5. Patients who participate in other clinical trials within one month 6. Patients who have received radiotherapy and/or chemotherapy within 2 months before surgery 7. Patients who have received mechanical ventilation with endotracheal intubation lasting more than 30min 1 month before surgery 8. Those who are considered by the investigator to be unable to participate in this clinical trial

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative pulmonary complications;

Secondary

MeasureTime frame
Incidence of complications within 7 days post operation;All-cause mortality within 30 days post operation;Length of postoperative hospital stay time;Postoperative quality recovery Scale;

Countries

China

Contacts

Public ContactBuwei Yu

Ruijin Hospital Shanghai Jiaotong University School of Medicine

yubuwei_2013@126.com+86 21 6437 0045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026